185 related articles for article (PubMed ID: 29945070)
1. The potential protective effects of cannabinoid receptor agonist WIN55,212-2 on cognitive dysfunction is associated with the suppression of autophagy and inflammation in an experimental model of vascular dementia.
Wang DP; Yin H; Kang K; Lin Q; Su SH; Hai J
Psychiatry Res; 2018 Sep; 267():281-288. PubMed ID: 29945070
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling.
Su SH; Wang YQ; Wu YF; Wang DP; Lin Q; Hai J
Behav Brain Res; 2016 Oct; 313():334-344. PubMed ID: 27424778
[TBL] [Abstract][Full Text] [Related]
3. The Cannabinoid Receptor Agonist WIN55,212-2 Ameliorates Hippocampal Neuronal Damage After Chronic Cerebral Hypoperfusion Possibly Through Inhibiting Oxidative Stress and ASK1-p38 Signaling.
Wang DP; Lv QL; Lin Q; Kang K; Jin KY; Hai J
Neurotox Res; 2020 Apr; 37(4):847-856. PubMed ID: 31808139
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion model by blocking NF-κB pathways.
Su SH; Wu YF; Lin Q; Hai J
Naunyn Schmiedebergs Arch Pharmacol; 2017 Dec; 390(12):1189-1200. PubMed ID: 28825114
[TBL] [Abstract][Full Text] [Related]
5. Oxiracetam ameliorates cognitive deficits in vascular dementia rats by regulating the expression of neuronal apoptosis/autophagy-related genes associated with the activation of the Akt/mTOR signaling pathway.
Xu J; Qi Q; Lv P; Dong Y; Jiang X; Liu Z
Braz J Med Biol Res; 2019; 52(11):e8371. PubMed ID: 31721903
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 suppress chronic cerebral hypoperfusion-induced neuronal apoptosis by inhibiting c-Jun N-terminal kinase signaling.
Su SH; Wu YF; Lin Q; Yu F; Hai J
Neuroscience; 2015 Aug; 301():563-75. PubMed ID: 25795598
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation.
Marchalant Y; Rosi S; Wenk GL
Neuroscience; 2007 Feb; 144(4):1516-22. PubMed ID: 17178196
[TBL] [Abstract][Full Text] [Related]
8. Nimodipine activates neuroprotective signaling events and inactivates autophages in the VCID rat hippocampus.
Hu M; Liu Z; Lv P; Wang H; Zhu Y; Qi Q; Xu J; Gao L
Neurol Res; 2017 Oct; 39(10):904-909. PubMed ID: 28782464
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effect of WIN 55,212-2 pretreatment against focal cerebral ischemia through activation of extracellular signal-regulated kinases in rats.
Hu B; Wang Q; Chen Y; Du J; Zhu X; Lu Y; Xiong L; Chen S
Eur J Pharmacol; 2010 Oct; 645(1-3):102-7. PubMed ID: 20667450
[TBL] [Abstract][Full Text] [Related]
10. WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway.
Fakhfouri G; Ahmadiani A; Rahimian R; Grolla AA; Moradi F; Haeri A
Neuropharmacology; 2012 Sep; 63(4):653-66. PubMed ID: 22634229
[TBL] [Abstract][Full Text] [Related]
11. Selective Modulator of Cannabinoid Receptor Type 2 Reduces Memory Impairment and Infarct Size During Cerebral Hypoperfusion and Vascular Dementia.
Jayant S; Sharma B
Curr Neurovasc Res; 2016; 13(4):289-302. PubMed ID: 27586843
[TBL] [Abstract][Full Text] [Related]
12. The Cannabinoid WIN 55,212-2 Reduces Delayed Neurologic Sequelae After Carbon Monoxide Poisoning by Promoting Microglial M2 Polarization Through ST2 Signaling.
Du JJ; Liu ZQ; Yan Y; Xiong J; Jia XT; Di ZL; Ren JJ
J Mol Neurosci; 2020 Mar; 70(3):422-432. PubMed ID: 31732924
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the CB
Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
[TBL] [Abstract][Full Text] [Related]
14. Tilianin Ameliorates Cognitive Dysfunction and Neuronal Damage in Rats with Vascular Dementia via p-CaMKII/ERK/CREB and ox-CaMKII-Dependent MAPK/NF-
Jiang H; Ashraf GM; Liu M; Zhao K; Wang Y; Wang L; Xing J; Alghamdi BS; Li Z; Liu R
Oxid Med Cell Longev; 2021; 2021():6673967. PubMed ID: 34527176
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid receptor activation prevents the effects of chronic mild stress on emotional learning and LTP in a rat model of depression.
Segev A; Rubin AS; Abush H; Richter-Levin G; Akirav I
Neuropsychopharmacology; 2014 Mar; 39(4):919-33. PubMed ID: 24141570
[TBL] [Abstract][Full Text] [Related]
16. Antineoplastic effect of WIN 55,212-2, a cannabinoid agonist, in a murine xenograft model of gastric cancer.
Oh JH; Lee JY; Baeg MK; Han KH; Choi MG; Park JM
Chemotherapy; 2013; 59(3):200-6. PubMed ID: 24335109
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK.
Feng YJ; Li YY; Lin XH; Li K; Cao MH
World J Gastroenterol; 2016 Nov; 22(43):9515-9524. PubMed ID: 27920472
[TBL] [Abstract][Full Text] [Related]
18. Naringenin Attenuates Cognitive Impairment in a Rat Model of Vascular Dementia by Inhibiting Hippocampal Oxidative Stress and Inflammatory Response and Promoting N-Methyl-D-Aspartate Receptor Signaling Pathway.
Zhang J; Zhang Y; Liu Y; Niu X
Neurochem Res; 2022 Nov; 47(11):3402-3413. PubMed ID: 36028734
[TBL] [Abstract][Full Text] [Related]
19. Influence of N-methyl D-aspartate receptor mechanism on WIN55,212-2-induced amnesia in rat dorsal hippocampus.
Jamali-Raeufy N; Nasehi M; Zarrindast MR
Behav Pharmacol; 2011 Oct; 22(7):645-54. PubMed ID: 21918382
[TBL] [Abstract][Full Text] [Related]
20. Gastrodin improves cognitive dysfunction and decreases oxidative stress in vascular dementia rats induced by chronic ischemia.
Li Y; Zhang Z
Int J Clin Exp Pathol; 2015; 8(11):14099-109. PubMed ID: 26823723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
